跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gastrin-17
首页
药物
Gastrin-17
Gastrin-17
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Monoclonal antibodies to progastrin
US 8158128 B2
申请人: GRIMES STEPHEN
优先权: 2005
US
4 件公开
Monoclonal antibodies to gastrin hormone
US 2006020119 A1
申请人: GRIMES STEPHEN
优先权: 2005
US
3 件公开
CN 1997669 A
申请人: RECEPTOR BIOLOGIX INC
优先权: 2004
CN
Combination therapy for the treatment of tumors
US 2009191232 A1
申请人: GEVAS PHILIP C
优先权: 2008
US
3 件公开
Method of treatment
US 2007031511 A1
申请人: BALDWIN GRAHAM S
优先权: 2003
US
Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes
US 7560425 B2
申请人: WARATAH PHARMACEUTICALS INC
优先权: 2003
US
Immunological methods for the treatment of gastrointestinal cancer
US 2005025770 A1
申请人: GEVAS PHILIP C
优先权: 2004
US
Gastrin peptide immunogenic composition
US 10328134 B2
申请人: TYG ONCOLOGY LTD
优先权: 2013
US
Use of gastridin-17 as biomarker for atrophic gastritis with increased risk of several related post-onset
CN 113514647 A
申请人: BIOHIT OY
优先权: 2014
CN
Recombinant G-17 protein and preparation of monoclonal antibodies
CN 109762058 A
申请人: HANGZHOU XIANZHI BIOLOGICAL TECH CO LTD
优先权: 2018
CN
Paired antibodies for detecting content of G17 in serum and application of paired antibodies
CN 111825765 A
申请人: LANGFANG TIANGUANG BIOTECHNOLOGY CO LTD
优先权: 2020
CN
第 1 / 2 页
上一页
下一页
药物
反馈